Plain-English translation of NCT04626167 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-phase surgical trial testing concomitant renal and urinary bladder allograft transplantation—meaning doctors will transplant both a donor kidney and a donor bladder into the same person. The study is for people whose kidneys are failing because of severe bladder dysfunction or complete bladder absence, and whose bladder problems haven't improved with medication or other treatments. Instead of reconstructing a bladder from intestines (the current standard), this trial explores whether using a donated bladder works better.
Many people with kidney failure also have bladders that don't work properly or are missing entirely. Currently, doctors must perform two separate procedures: reconstruct or replace the bladder using intestines, and then later transplant a new kidney. This trial exists to see whether transplanting a real donor bladder at the same time as the kidney transplant could be safer, more effective, and require fewer surgeries overall.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have baseline evaluations to confirm you meet all study requirements. You will then undergo surgery to receive a transplanted donor bladder and a transplanted donor kidney. After surgery, you will need to learn and use clean intermittent catheterization to empty your bladder, and you will be monitored closely by the transplant team to ensure the new organs are working. You will also need to take immunosuppressant medications for life to prevent your body from rejecting the transplanted organs, and commit to regular follow-up visits and evaluations.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States